These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations. Christensen D; Foged C; Rosenkrands I; Lundberg CV; Andersen P; Agger EM; Nielsen HM Int J Pharm; 2010 May; 390(1):19-24. PubMed ID: 19879346 [TBL] [Abstract][Full Text] [Related]
29. Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration. Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X J Med Virol; 2015 Nov; 87(11):1807-15. PubMed ID: 25959372 [TBL] [Abstract][Full Text] [Related]
30. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization. Wu Y; Wei W; Zhou M; Wang Y; Wu J; Ma G; Su Z Biomaterials; 2012 Mar; 33(7):2351-60. PubMed ID: 22192540 [TBL] [Abstract][Full Text] [Related]
31. A novel antigen-carrier system: the Mycobacterium tuberculosis Acr protein carried by raw starch microparticles. Moreno-Mendieta SA; Guillén D; Espitia C; Hernández-Pando R; Sanchez S; Rodríguez-Sanoja R Int J Pharm; 2014 Oct; 474(1-2):241-8. PubMed ID: 25093695 [TBL] [Abstract][Full Text] [Related]
32. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339 [TBL] [Abstract][Full Text] [Related]
33. Intranasal immunization against influenza virus using polymeric particles. Lemoine D; Deschuyteneer M; Hogge F; Préat V J Biomater Sci Polym Ed; 1999; 10(8):805-25. PubMed ID: 10487316 [TBL] [Abstract][Full Text] [Related]
34. Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery. Bae HD; Lee J; Jin XH; Lee K Mol Pharm; 2016 Sep; 13(9):3196-205. PubMed ID: 27454469 [TBL] [Abstract][Full Text] [Related]
35. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice. Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512 [TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo. Vu-Quang H; Yoo MK; Jeong HJ; Lee HJ; Muthiah M; Rhee JH; Lee JH; Cho CS; Jeong YY; Park IK Acta Biomater; 2011 Nov; 7(11):3935-45. PubMed ID: 21763797 [TBL] [Abstract][Full Text] [Related]
37. Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination. Zhen Y; Wang N; Gao Z; Ma X; Wei B; Deng Y; Wang T Vaccine; 2015 Aug; 33(35):4330-40. PubMed ID: 25858854 [TBL] [Abstract][Full Text] [Related]
38. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. Tafaghodi M; Sajadi Tabassi SA; Jaafari MR Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972 [TBL] [Abstract][Full Text] [Related]
39. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin. Kang ML; Jiang HL; Kang SG; Guo DD; Lee DY; Cho CS; Yoo HS Vaccine; 2007 Jun; 25(23):4602-10. PubMed ID: 17485148 [TBL] [Abstract][Full Text] [Related]
40. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin. Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]